Discoverkeep provides a consent‑based lived‑experience platform that continuously captures real‑time health signals and conversations from patients with rare and specialty diseases in their home environment. By enrolling patients within days, the system aggregates daily data into actionable insights that pharma commercial and market‑access teams can use to monitor treatment adherence, side effects, and patient sentiment, and to inform timely interventions and competitive intelligence.
Funding
$2.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Pharmaceutical companies rely on retrospective data sources such as surveys, claims, and small advisory panels, which capture patient experiences only after decisions have been made, leaving a gap in real‑time insight into how patients actually live with their therapies at home.
Solution
Discoverkeep offers a continuous, consent‑based lived‑experience platform that captures real‑time signals from patients with rare and specialty diseases directly in their home environment. By enrolling patients within days, the system aggregates daily conversations and health signals, compounding them into actionable intelligence that reflects current patient behavior and sentiment. This intelligence is routed to pharma teams and agencies before critical decision windows close, enabling timely interventions, retention strategies, and more accurate brand awareness. The platform supports monitoring of both a sponsor’s own patients and competitors’ patients, providing a comprehensive view of therapeutic performance across the market.
Target Audience
Primary customers are pharmaceutical brands and their commercial or market‑access teams seeking real‑time patient insights for rare and specialty disease therapies.
Features
- Rapid patient enrollment pipeline that brings target‑audience participants online in days rather than months
- Continuous, real‑time data collection from patients’ daily lives, generating over 50,000 conversations and growing
- Aggregated signals that compound monthly, delivering up‑to‑date insights into treatment adherence, side effects, and quality of life
- Consent‑driven architecture ensuring all patient data is collected ethically and can be routed to pharma or agency teams as needed
- Comparative analytics across sponsor and competitor patient cohorts for holistic market intelligence
- Dashboard and API access that deliver actionable alerts to inform retention interventions and strategic decisions